Journal article 1027 views 823 downloads
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Thinzar Min,
Steve Bain 
Diabetes Therapy, Volume: 12, Issue: 1, Pages: 143 - 157
Swansea University Authors:
Thinzar Min, Steve Bain
-
PDF | Version of Record
©The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Download (379.28KB)
DOI (Published version): 10.1007/s13300-020-00981-0
Abstract
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
| Published in: | Diabetes Therapy |
|---|---|
| ISSN: | 1869-6953 1869-6961 |
| Published: |
Springer Science and Business Media LLC
2021
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa55784 |
| Keywords: |
Glucagon-like peptide 1; Glucose-dependent insulinotropic polypeptide; Incretin hormone; Type 2 diabetes; Tirzepatide |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
1 |
| Start Page: |
143 |
| End Page: |
157 |